OBJECTIVE: Antibiotic-resistant bacterial biofilm may quickly form on endotracheal tubes (ETTs) and can enter the lungs, potentially causing pneumonia. In an attempt to prevent bacterial colonization, we developed and tested in an in-vitro study and animal study several antibacterial-coated ETTs (silver sulfadiazine with and without carbon in polyurethane, silver sulfadiazine and chlorhexidine with and without carbon in polyurethane, silver-platinum with and without carbon in polyurethane, chlorhexidine in polyurethane, and rose bengal for UV light). DESIGN, SETTING, ANIMALS, INTERVENTIONS: After preliminary studies, silver sulfadiazine in polyurethane (SSD-ETT) was selected among the coatings to be challenged every 24 h with 10(4)-10(6) Pseudomonas aeruginosa/ml and evaluated at 6 h, 24 h, and 72 h with standard microbiological studies, scanning electron microscopy, and confocal scanning microscopy. Subsequently, eight sheep were randomized to receive either a SSD-ETT or a standard ETT (St-ETT). After 24 h of mechanical ventilation, standard microbiological studies were performed together with scanning electron microscopy and confocal microscopy. MEASUREMENTS AND RESULTS: In the in-vitro study SSD-ETT remained bacteria-free for up to 72 h, whereas St-ETT showed heavy P. aeruginosa growth and biofilm formation (p < 0.01). In sheep, the SSD-ETT group showed no bacterial growth in the ETT, ventilator tubing, and lower respiratory tract, while heavy colonization was found in the St-ETT (p < 0.01), ventilator tubing (p=0.03), and lower respiratory tract (p < 0.01). CONCLUSION: This study describes several effective and durable antibacterial coatings for ETTs. Particularly, SSD-ETT showed prevention against P. aeruginosa biofilm formation in a 72-h in-vitro study and lower respiratory tract colonization in sheep mechanically ventilated for 24 h.
OBJECTIVE: Antibiotic-resistant bacterial biofilm may quickly form on endotracheal tubes (ETTs) and can enter the lungs, potentially causing pneumonia. In an attempt to prevent bacterial colonization, we developed and tested in an in-vitro study and animal study several antibacterial-coated ETTs (silver sulfadiazine with and without carbon in polyurethane, silver sulfadiazine and chlorhexidine with and without carbon in polyurethane, silver-platinum with and without carbon in polyurethane, chlorhexidine in polyurethane, and rose bengal for UV light). DESIGN, SETTING, ANIMALS, INTERVENTIONS: After preliminary studies, silver sulfadiazine in polyurethane (SSD-ETT) was selected among the coatings to be challenged every 24 h with 10(4)-10(6) Pseudomonas aeruginosa/ml and evaluated at 6 h, 24 h, and 72 h with standard microbiological studies, scanning electron microscopy, and confocal scanning microscopy. Subsequently, eight sheep were randomized to receive either a SSD-ETT or a standard ETT (St-ETT). After 24 h of mechanical ventilation, standard microbiological studies were performed together with scanning electron microscopy and confocal microscopy. MEASUREMENTS AND RESULTS: In the in-vitro study SSD-ETT remained bacteria-free for up to 72 h, whereas St-ETT showed heavy P. aeruginosa growth and biofilm formation (p < 0.01). In sheep, the SSD-ETT group showed no bacterial growth in the ETT, ventilator tubing, and lower respiratory tract, while heavy colonization was found in the St-ETT (p < 0.01), ventilator tubing (p=0.03), and lower respiratory tract (p < 0.01). CONCLUSION: This study describes several effective and durable antibacterial coatings for ETTs. Particularly, SSD-ETT showed prevention against P. aeruginosa biofilm formation in a 72-h in-vitro study and lower respiratory tract colonization in sheep mechanically ventilated for 24 h.
Authors: Jordi Rello; Marin Kollef; Emili Diaz; Albert Sandiumenge; Yolanda del Castillo; Xavier Corbella; Regina Zachskorn Journal: Crit Care Med Date: 2006-11 Impact factor: 7.598
Authors: Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein Journal: MMWR Recomm Rep Date: 2002-08-09
Authors: Lorenzo Berra; Theodor Kolobow; Patrice Laquerriere; Betsey Pitts; Simone Bramati; Joshua Pohlmann; Chiara Marelli; Miriam Panzeri; Pietro Brambillasca; Federico Villa; Andrea Baccarelli; Sylvie Bouthors; Henry T Stelfox; Luca M Bigatello; Joel Moss; Antonio Pesenti Journal: Intensive Care Med Date: 2008-04-17 Impact factor: 17.440
Authors: D J Balazs; K Triandafillu; P Wood; Y Chevolot; C van Delden; H Harms; C Hollenstein; H J Mathieu Journal: Biomaterials Date: 2004-05 Impact factor: 12.479
Authors: J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer Journal: JAMA Date: 1995 Aug 23-30 Impact factor: 56.272
Authors: Amanda C Zangirolami; Lucas D Dias; Kate C Blanco; Carolina S Vinagreiro; Natalia M Inada; Luis G Arnaut; Mariette M Pereira; Vanderlei S Bagnato Journal: Proc Natl Acad Sci U S A Date: 2020-08-31 Impact factor: 11.205
Authors: Lorenzo Berra; Theodor Kolobow; Patrice Laquerriere; Betsey Pitts; Simone Bramati; Joshua Pohlmann; Chiara Marelli; Miriam Panzeri; Pietro Brambillasca; Federico Villa; Andrea Baccarelli; Sylvie Bouthors; Henry T Stelfox; Luca M Bigatello; Joel Moss; Antonio Pesenti Journal: Intensive Care Med Date: 2008-04-17 Impact factor: 17.440
Authors: Scott Cairns; John Gilbert Thomas; Samuel James Hooper; Matthew Peter Wise; Paul John Frost; Melanie Julia Wilson; Michael Alexander Oxenham Lewis; David Wynne Williams Journal: PLoS One Date: 2011-03-14 Impact factor: 3.240
Authors: Rhea M May; Matthew G Hoffman; Melinda J Sogo; Albert E Parker; George A O'Toole; Anthony B Brennan; Shravanthi T Reddy Journal: Clin Transl Med Date: 2014-04-16
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2008-12-09 Impact factor: 17.440